Selected research
Industry Research
Neonatal Immune Cell Storage Service Industry Research Report 2026
Market perspective
The global Neonatal Immune Cell Storage Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Neonatal Immune Cell Storage Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Neonatal Immune Cell Storage Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Neonatal Immune Cell Storage Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Neonatal Immune Cell Storage Service include Shanghai Cell Therapy Group, BGI Group, VCANBIO, CGT GLOBAL, Cordlife Group, ThermoGenesis, HealthBanks, BioLife Solutions and Sartorius, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Neonatal Immune Cell Storage Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Neonatal Immune Cell Storage Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neonatal Immune Cell Storage Service Market by Company
Shanghai Cell Therapy Group
BGI Group
VCANBIO
CGT GLOBAL
Cordlife Group
ThermoGenesis
HealthBanks
BioLife Solutions
Sartorius
CGT GLOBAL
Cordlife Group
Aeterna Health
Cell Vault
Redermis
Innovita Research
Neonatal Immune Cell Storage Service Segment by Type
100ml Blood Collection Volume
150ml Blood Collection Volume
200ml Blood Collection Volume
Neonatal Immune Cell Storage Service Segment by Application
Personal
Commercial
Neonatal Immune Cell Storage Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neonatal Immune Cell Storage Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neonatal Immune Cell Storage Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neonatal Immune Cell Storage Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Neonatal Immune Cell Storage Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 100ml Blood Collection Volume
- 150ml Blood Collection Volume
- 200ml Blood Collection Volume
Applications
- Personal
- Commercial
Companies covered
- Shanghai Cell Therapy Group
- BGI Group
- VCANBIO
- CGT GLOBAL
- Cordlife Group
- ThermoGenesis
- HealthBanks
- BioLife Solutions
- Sartorius
- CGT GLOBAL
- Cordlife Group
- Aeterna Health
- Cell Vault
- Redermis
- Innovita Research
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Neonatal Immune Cell Storage Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 100ml Blood Collection Volume
- 2.2.3 150ml Blood Collection Volume
- 2.2.4 200ml Blood Collection Volume
- 2.3 Neonatal Immune Cell Storage Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Personal
- 2.3.3 Commercial
- 2.4 Assumptions and Limitations
3 Neonatal Immune Cell Storage Service Breakdown Data by Type
- 3.1 Global Neonatal Immune Cell Storage Service Historic Market Size by Type (2021-2026)
- 3.2 Global Neonatal Immune Cell Storage Service Forecasted Market Size by Type (2027-2032)
4 Neonatal Immune Cell Storage Service Breakdown Data by Application
- 4.1 Global Neonatal Immune Cell Storage Service Historic Market Size by Application (2021-2026)
- 4.2 Global Neonatal Immune Cell Storage Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Neonatal Immune Cell Storage Service Market Perspective (2021-2032)
- 5.2 Global Neonatal Immune Cell Storage Service Growth Trends by Region
- 5.2.1 Global Neonatal Immune Cell Storage Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Neonatal Immune Cell Storage Service Historic Market Size by Region (2021-2026)
- 5.2.3 Neonatal Immune Cell Storage Service Forecasted Market Size by Region (2027-2032)
- 5.3 Neonatal Immune Cell Storage Service Market Dynamics
- 5.3.1 Neonatal Immune Cell Storage Service Industry Trends
- 5.3.2 Neonatal Immune Cell Storage Service Market Drivers
- 5.3.3 Neonatal Immune Cell Storage Service Market Challenges
- 5.3.4 Neonatal Immune Cell Storage Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Neonatal Immune Cell Storage Service Players by Revenue
- 6.1.1 Global Top Neonatal Immune Cell Storage Service Players by Revenue (2021-2026)
- 6.1.2 Global Neonatal Immune Cell Storage Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Neonatal Immune Cell Storage Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Neonatal Immune Cell Storage Service Head Office and Area Served
- 6.4 Global Neonatal Immune Cell Storage Service Players, Product Type & Application
- 6.5 Global Neonatal Immune Cell Storage Service Manufacturers Established Date
- 6.6 Global Neonatal Immune Cell Storage Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Neonatal Immune Cell Storage Service Market Size (2021-2032)
- 7.2 North America Neonatal Immune Cell Storage Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Neonatal Immune Cell Storage Service Market Size by Country (2021-2026)
- 7.4 North America Neonatal Immune Cell Storage Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Neonatal Immune Cell Storage Service Market Size (2021-2032)
- 8.2 Europe Neonatal Immune Cell Storage Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Neonatal Immune Cell Storage Service Market Size by Country (2021-2026)
- 8.4 Europe Neonatal Immune Cell Storage Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Neonatal Immune Cell Storage Service Market Size (2021-2032)
- 9.2 Asia-Pacific Neonatal Immune Cell Storage Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Neonatal Immune Cell Storage Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Neonatal Immune Cell Storage Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Neonatal Immune Cell Storage Service Market Size (2021-2032)
- 10.2 South America Neonatal Immune Cell Storage Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Neonatal Immune Cell Storage Service Market Size by Country (2021-2026)
- 10.4 South America Neonatal Immune Cell Storage Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Neonatal Immune Cell Storage Service Market Size (2021-2032)
- 11.2 Middle East & Africa Neonatal Immune Cell Storage Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Neonatal Immune Cell Storage Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Neonatal Immune Cell Storage Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Shanghai Cell Therapy Group
- 12.1.1 Shanghai Cell Therapy Group Company Information
- 12.1.2 Shanghai Cell Therapy Group Business Overview
- 12.1.3 Shanghai Cell Therapy Group Revenue in Neonatal Immune Cell Storage Service Business (2021-2026)
- 12.1.4 Shanghai Cell Therapy Group Neonatal Immune Cell Storage Service Product Portfolio
- 12.1.5 Shanghai Cell Therapy Group Recent Developments
- 12.2 BGI Group
- 12.2.1 BGI Group Company Information
- 12.2.2 BGI Group Business Overview
- 12.2.3 BGI Group Revenue in Neonatal Immune Cell Storage Service Business (2021-2026)
- 12.2.4 BGI Group Neonatal Immune Cell Storage Service Product Portfolio
- 12.2.5 BGI Group Recent Developments
- 12.3 VCANBIO
- 12.3.1 VCANBIO Company Information
- 12.3.2 VCANBIO Business Overview
- 12.3.3 VCANBIO Revenue in Neonatal Immune Cell Storage Service Business (2021-2026)
- 12.3.4 VCANBIO Neonatal Immune Cell Storage Service Product Portfolio
- 12.3.5 VCANBIO Recent Developments
- 12.4 CGT GLOBAL
- 12.4.1 CGT GLOBAL Company Information
- 12.4.2 CGT GLOBAL Business Overview
- 12.4.3 CGT GLOBAL Revenue in Neonatal Immune Cell Storage Service Business (2021-2026)
- 12.4.4 CGT GLOBAL Neonatal Immune Cell Storage Service Product Portfolio
- 12.4.5 CGT GLOBAL Recent Developments
- 12.5 Cordlife Group
- 12.5.1 Cordlife Group Company Information
- 12.5.2 Cordlife Group Business Overview
- 12.5.3 Cordlife Group Revenue in Neonatal Immune Cell Storage Service Business (2021-2026)
- 12.5.4 Cordlife Group Neonatal Immune Cell Storage Service Product Portfolio
- 12.5.5 Cordlife Group Recent Developments
- 12.6 ThermoGenesis
- 12.6.1 ThermoGenesis Company Information
- 12.6.2 ThermoGenesis Business Overview
- 12.6.3 ThermoGenesis Revenue in Neonatal Immune Cell Storage Service Business (2021-2026)
- 12.6.4 ThermoGenesis Neonatal Immune Cell Storage Service Product Portfolio
- 12.6.5 ThermoGenesis Recent Developments
- 12.7 HealthBanks
- 12.7.1 HealthBanks Company Information
- 12.7.2 HealthBanks Business Overview
- 12.7.3 HealthBanks Revenue in Neonatal Immune Cell Storage Service Business (2021-2026)
- 12.7.4 HealthBanks Neonatal Immune Cell Storage Service Product Portfolio
- 12.7.5 HealthBanks Recent Developments
- 12.8 BioLife Solutions
- 12.8.1 BioLife Solutions Company Information
- 12.8.2 BioLife Solutions Business Overview
- 12.8.3 BioLife Solutions Revenue in Neonatal Immune Cell Storage Service Business (2021-2026)
- 12.8.4 BioLife Solutions Neonatal Immune Cell Storage Service Product Portfolio
- 12.8.5 BioLife Solutions Recent Developments
- 12.9 Sartorius
- 12.9.1 Sartorius Company Information
- 12.9.2 Sartorius Business Overview
- 12.9.3 Sartorius Revenue in Neonatal Immune Cell Storage Service Business (2021-2026)
- 12.9.4 Sartorius Neonatal Immune Cell Storage Service Product Portfolio
- 12.9.5 Sartorius Recent Developments
- 12.10 CGT GLOBAL
- 12.10.1 CGT GLOBAL Company Information
- 12.10.2 CGT GLOBAL Business Overview
- 12.10.3 CGT GLOBAL Revenue in Neonatal Immune Cell Storage Service Business (2021-2026)
- 12.10.4 CGT GLOBAL Neonatal Immune Cell Storage Service Product Portfolio
- 12.10.5 CGT GLOBAL Recent Developments
- 12.11 Cordlife Group
- 12.11.1 Cordlife Group Company Information
- 12.11.2 Cordlife Group Business Overview
- 12.11.3 Cordlife Group Revenue in Neonatal Immune Cell Storage Service Business (2021-2026)
- 12.11.4 Cordlife Group Neonatal Immune Cell Storage Service Product Portfolio
- 12.11.5 Cordlife Group Recent Developments
- 12.12 Aeterna Health
- 12.12.1 Aeterna Health Company Information
- 12.12.2 Aeterna Health Business Overview
- 12.12.3 Aeterna Health Revenue in Neonatal Immune Cell Storage Service Business (2021-2026)
- 12.12.4 Aeterna Health Neonatal Immune Cell Storage Service Product Portfolio
- 12.12.5 Aeterna Health Recent Developments
- 12.13 Cell Vault
- 12.13.1 Cell Vault Company Information
- 12.13.2 Cell Vault Business Overview
- 12.13.3 Cell Vault Revenue in Neonatal Immune Cell Storage Service Business (2021-2026)
- 12.13.4 Cell Vault Neonatal Immune Cell Storage Service Product Portfolio
- 12.13.5 Cell Vault Recent Developments
- 12.14 Redermis
- 12.14.1 Redermis Company Information
- 12.14.2 Redermis Business Overview
- 12.14.3 Redermis Revenue in Neonatal Immune Cell Storage Service Business (2021-2026)
- 12.14.4 Redermis Neonatal Immune Cell Storage Service Product Portfolio
- 12.14.5 Redermis Recent Developments
- 12.15 Innovita Research
- 12.15.1 Innovita Research Company Information
- 12.15.2 Innovita Research Business Overview
- 12.15.3 Innovita Research Revenue in Neonatal Immune Cell Storage Service Business (2021-2026)
- 12.15.4 Innovita Research Neonatal Immune Cell Storage Service Product Portfolio
- 12.15.5 Innovita Research Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst